Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor

Biochemistry

Volumn 47, Issue 10, 2008, Pages 3117-3130

  Nikiforovich, Gregory V ^a   Marshall, Garland R ^a   Baranski, Thomas J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; MATHEMATICAL MODELS; POLYPEPTIDES; PROTEINS; THREE DIMENSIONAL;

MOLECULAR MECHANISMS; POLYPEPTIDE LIGANDS;

MOLECULAR MODELING;

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR;

ARTICLE; COMPLEMENT FIXATION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; COMPLEMENT C5A; COMPUTER SIMULATION; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANAPHYLATOXIN C5A;

EID: 40549111917     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702321a     Document Type: Article

References (59)

1. Allegretti, M., Moriconi, A., Beccari, A. R., Di Bitondo, R., Bizzarri, C., Bertini, R., and Colotta, F. (2005) Targeting C5a: Recent advances in drug discovery. Curr. Med. Chem. 12, 217-236.
2. Zuiderweg, E. R., Nettesheim, D. G., Mollison, K. W., and Carter, G. W. (1989) Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochemistry 28, 172-185.
3. Zhang, X., Boyar, W., Toth, M. J., Wennogle, L., and Gonnella, N. C. (1997) Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins 28, 261-267.
4. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745.
5. Teller, D. C., Okada, T., Behnke, C. A., Palczewski, K., and Stenkamp, R. E. (2001) Advances in determination of a high-resoultion three-dimensional structure of rhodpsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40, 7761-7772.
6. Okada, T., Fujiyoshi, Y., Silow, M., Navarro, J., Landau, E. M., and Shichida, Y. (2002) Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. U.S.A. 99, 5982-5987.
7. Okada, T., Sugihara, M., Bondar, A. N., Elstner, M., Entel, P., and Buss, V. (2004) The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J. Mol. Biol. 342, 571-583.
8. Li, J., Edwards, P. C., Burghammer, M., Villa, C., and Schertler, G. F. (2004) Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409-1438.
9. Rasmussen, S. G., Choi, H. J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R., Sanishvili, R., Fischetti, R. F., Schertler, G. F., Weis, W. I., and Kobilka, B. K. (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383-387.
10. Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G., Thian, F. S., Kobilka, T. S., Choi, H. J., Kuhn, P., Weis, W. I., Kobilka, B. K., and Stevens, R. C. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258-1265.
11. Drews, J. (2000) Drug discovery: A historical perspective. Science 287, 1960-1964.
12. Mollison, K. W., Mandecki, W., Zuiderweg, E. R., Fayer, L., Fey, T. A., Krause, R. A., Conway, R. G., Miller, L., Edalji, R. P., and Shallcross, M. A. (1989) Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 86, 292-296.
13. Siciliano, S. J., Rollins, T. E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., and Springer, M. S. (1994) Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 91, 1214-1218.
14. DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994) The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269, 14446-14450.
15. Kawai, M., Quincy, D. A., Lane, B., Mollison, K. W., Luly, J. R., and Carter, G. W. (1991) Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. J. Med. Chem. 34, 2068-2071.
16. Bubeck, P., Grotzinger, J., Winkler, M., Kohl, J., Wollmer, A., Klos, A., and Bautsch, W. (1994) Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. Eur. J. Biochem. 219, 897-904.
17. Toth, M. J., Huwyler, L., Boyar, W. C., Braunwalder, A. F., Yarwood, D., Hadala, J., Haston, W. O., Sills, M. A., Seligmann, B., and Galakatos, N. (1994) The pharmacophore of the human C5a anaphylatoxin. Protein Sci. 3, 1159-1168.
18. 2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J. Biol. Chem. 269, 3457-3463.
19. Chen, Z., Zhang, X., Gonnella, N. C., Pellas, T. C., Boyar, W. C., and Ni, F. (1998) Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin. J. Biol. Chem. 273, 10411-10419.
20. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., Kuhn, J., Gerard, C., Gerard, N. P., and Choe, H. (2001) Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J. Exp. Med. 193, 1059-1066.
21. Hagemann, I. S., Narzinski, K. D., Floyd, D. H., and Baranski, T. J. (2006) Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking. J. Biol. Chem. 281, 36783-36792.
22. Hageman, I. S., Miller, D. L., Klco, J. M., Nikiforovich, G. V., and Baranski, T. J. (2008) Structure of the complement factor 5a (C5a) receptor/ligand complex studied by disulfide trapping and molecular modeling, J. Biol. Chem. E-publication ahead of print: PMID 18195008.
23. Crass, T., Bautsch, W., Cain, S. A., Pease, J. E., and Monk, P. N. (1999) Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand. Biochemistry 38, 9712-9717.
24. Monk, P. N., Barker, M. D., Partridge, L. J., and Pease, J. E. (1995) Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. J. Biol. Chem. 270, 16625-16629.
25. Cain, S. A., Higginbottom, A., and Monk, P. N. (2003) Characterisation of C5a receptor agonists from phage display libraries. Biochem. Pharmacol. 66, 1833-1840.
26. Raffetseder, U., Roper, D., Mery, L., Gietz, C., Klos, A., Grotzinger, J., Wollmer, A., Boulay, F., Kohl, J., and Bautsch, W. (1996) Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. Eur. J. Biochem. 235, 82-90.
27. Cain, S. A., Coughlan, T., and Monk, P. N. (2001) Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor. Biochemistry 40, 14047-14052.
28. DeMartino, J. A., Konteatis, Z. D., Siciliano, S. J., Van Riper, G., Underwood, D. J., Fischer, P. A., and Springer, M. S. (1995) Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol. Chem. 270, 15966-15969.
29. Higginbottom, A., Cain, S. A., Woodruff, T. M., Proctor, L. M., Madala, P. K., Tyndall, J. D., Taylor, S. M., Fairlie, D. P., and Monk, P. N. (2005) Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J. Biol. Chem. 280, 17831-17840.
30. Cain, S. A., Woodruff, T. M., Taylor, S. M., Fairlie, D. P., Sanderson, S. D., and Monk, P. N. (2001) Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor. Biochem. Pharmacol. 61, 1571-1579.
31. Gerber, B. O., Meng, E. C., Dotsch, V., Baranski, T. J., and Bourne, H. R. (2001) An activation switch in the ligand binding pocket of the C5a receptor. J. Biol. Chem. 276, 3394-3400.
32. Nikiforovich, G. V., and Marshall, G. R. (2005) Modeling flexible loops in the dark-adapted and activated states of rhodopsin, a prototypical G-protein coupled receptor. Biophys. J. 89, 3780-3789.
33. Matsumoto, M. L., Narzinski, K., Kiser, P. D., Nikiforovich, G. V., and Baranski, T. J. (2007) A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues. J. Biol. Chem. 282, 3105-3121.
34. Nikiforovich, G. V., Taylor, C. M., and Marshall, G. R. (2007) Modeling of the complex between transducin and photoactivated rhodopsin, a prototypical G-protein-coupled receptor. Biochemistry 46, 4734-4744.
35. Dunfield, L. G., Burgess, A. W., and Scheraga, H. A. (1978) Energy parameters in polypeptides. 8. Empirical potential energy algorithm for the conformational analysis of large molecules. J. Phys. Chem. 82, 2609-2616.
36. Nemethy, G., Pottle, M. S., and Scheraga, H. A. (1983) Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occuring amino acids. J. Phys. Chem. 87, 1883-1887.
37. Nikiforovich, G. V. (1994) Computational molecular modeling in peptide design. Int. J. Pept. Protein Res. 44, 513-531.
38. Gerard, C., and Gerard, N. P. (1994) C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808.
39. Nikiforovich, G. V., Zhang, M., Yang, Q., Jagadeesh, G., Chen, H. C., Hunyady, L., Marshall, G. R., and Catt, K. J. (2006) Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chem. Biol. Drug Des. 68, 239-249.
40. Nikiforovich, G. V., Hruby, V. J., Prakash, O., and Gehrig, C. A. (1991) Topographical requirements for delta-selective opioid peptides. Biopolymers 31, 941-955.
41. Finch, A. M., Vogen, S. M., Sherman, S. A., Kirnarsky, L., Taylor, S. M., and Sanderson, S. D. (1997) Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity. J. Med. Chem. 40, 877-884.
42. Vogen, S. M., Prakash, O., Kirnarsky, L., Sanderson, S. D., and Sherman, S. A. (1999) Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin. J. Pept. Res. 54, 74-84.
43. Fernandez, H. N., and Hugh, T. E. (1978) Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J. Biol. Chem. 253, 6955-6964.
44. Klco, J. M., Nikiforovich, G. V., and Baranski, T. J. (2006) Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop. J. Biol. Chem. 281, 12010-12019.
45. Vogen, S. M., Finch, A. M., Wadi, S. K., Thatcher, J., Monk, P. N., Taylor, S. M., and Sanderson, S. D. (1999) The influence of Lys68 in decapeptide agonists of C5a on C5a receptor binding, activation and selectivity. J. Pept. Res. 53, 8-17.
46. Cain, S. A., and Monk, P. N. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277, 7165-7169.
47. Scola, A. M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T., Taylor, S. M., Fairlie, D. P., and Monk, P. N. (2007) The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J. Biol. Chem. 282, 3664-3671.
48. Salom, D., Lodowski, D. T., Stenkamp, R. E., Le Trong, I., Golczak, M., Jastrzebska, B., Harris, T., Ballesteros, J. A., and Palczewski, K. (2006) Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 103, 16123-16128.
49. Hubbell, W. L., Altenbach, C., and Khorana, H. G. (2003) Rhodopsin structure, dynamics and activation. Adv. Protein Chem. 63, 243-290.
50. Pogozheva, I. D., Przydzial, M. J., and Mosberg, H. I. (2005) Homology modeling of opioid receptor-ligand complexes using experimental constraints. AAPS J. 7, E434-E448.
51. Pogozheva, I. D., Chai, B. X., Lomize, A. L., Fong, T. M., Weinberg, D. H., Nargund, R. P., Mulholland, M. W., Gantz, I., and Mosberg, H. I. (2005) Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists. Biochemistry 44, 11329-11341.
52. Clement, M., Martin, S. S., Beaulieu, M. E., Chamberland, C., Lavigne, P., Leduc, R., Guillemette, G., and Escher, E. (2005) Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. J. Biol. Chem. 280, 27121-27129.
53. Oliveira, L., Costa-Neto, C. M., Nakaie, C. R., Schreier, S., Shimuta, S. I., and Paiva, A. C. (2007) The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure. Physiol. Rev. 87, 565-592.
54. Sköld, C., Nikiforovich, G. V., and Karlen, A. (2008) Model of the angiotensin II type-2 receptor for exploring the binding mode of angiotensin II and pseudopeptide analogues, J. Mol. Graphics Modell. 26, 991-1003.
55. Nikiforovich, G. V., and Marshall, G. R. (2001) 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem. Biophys. Res. Commun. 286, 1204-1211.
56. Vabeno, J., Nikiforovich, G. V., and Marshall, G. R. (2006) Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor. Chem. Biol. Drug Des. 67, 346-354.
57. Slusarz, M. J., Sikorska, E., Slusarz, R., and Ciarkowski, J. (2006) Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: Influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors. J. Med. Chem. 49, 2463-2469.
58. Slusarz, M. J., Slusarz, R., and Ciarkowski, J. (2006) Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system. Biopolymers 81, 321-338.
59. Crump, M. P., Gong, J. H., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana-Seisdedos, F., Virelizier, J. L., Baggiolini, M., Sykes, B. D., and Clark-Lewis, I. (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996-7007.